Cargando…
A potent and selective small molecule inhibitor of myoferlin attenuates colorectal cancer progression
As a pivotal vesicular trafficking protein, Myoferlin (MYOF) has become an attractive target for cancer therapy. However, the roles of MYOF in colorectal cancer invasion remain enigmatic, and MYOF‐targeted therapy in this malignancy has not been explored. In the present study, we provided the first...
Autores principales: | He, Yuan, Kan, Weiqiong, Li, Yunqi, Hao, Yun, Huang, Anling, Gu, Haijun, Wang, Minna, Wang, Qingqing, Chen, Jinlian, Sun, Zhenliang, Liu, Mingyao, Chen, Yihua, Yi, Zhengfang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7868085/ https://www.ncbi.nlm.nih.gov/pubmed/33634965 http://dx.doi.org/10.1002/ctm2.289 |
Ejemplares similares
-
A small molecule targeting myoferlin exerts promising anti-tumor effects on breast cancer
por: Zhang, Tao, et al.
Publicado: (2018) -
Targeting Pyruvate Carboxylase by a Small Molecule Suppresses Breast Cancer Progression
por: Lin, Qingxiang, et al.
Publicado: (2020) -
A novel synthetic small molecule YH-306 suppresses colorectal tumour growth and metastasis viaFAK pathway
por: Dai, Fujun, et al.
Publicado: (2015) -
Myoferlin disturbs redox equilibrium to accelerate gastric cancer migration
por: Shi, Hailong, et al.
Publicado: (2022) -
Myoferlin, a Membrane Protein with Emerging Oncogenic Roles
por: Dong, Yimin, et al.
Publicado: (2019)